Nicox Provides Fourth Quarter 2023 Financial and Business
NCX 470 Phase 3 Denali clinical trial 75% randomizedNet revenue €1.3 million for fourth quarter 2023 and €4.2 million for ...
Read moreNCX 470 Phase 3 Denali clinical trial 75% randomizedNet revenue €1.3 million for fourth quarter 2023 and €4.2 million for ...
Read moreDecember 18, 2023 – release at 7:30 am CETSophia Antipolis, FranceNicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.